pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 308
- Drugs
- 443
- Patents
- 706
Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT)
Phase 3 · small molecule · Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
Instant MSC Product accompanying Autologous Chondron Transplantation (IMPACT) for Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea) is a Phase 3 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Disc Medicine
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Symptomatic articular cartilage lesion of the knee (femoral condyles or trochlea)
- Status
- active
- Trials
- 1